IFN-γ-release assays to diagnose TB infection in the immunocompromised individual

References

• Global tuberculosis control: surveillance, planning, financing. WHO report. WHO, Geneva, Switzerland (WHO/HTM/TB/2005.349) (2005).
   Google Scholar
• Jasmer RM, Nahid P, Hopewell PC. Clinical practice. Latent tuberculosis infection. N. Engl. J. Med.347(23), 1860–1866 (2002).
   PubMed Web of Science ®Google Scholar
• Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin. Infect. Dis.17(6), 968–975 (1993).
   PubMed Web of Science ®Google Scholar
• Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N. Engl. J. Med.350(20), 2060–2067 (2004).
   PubMed Web of Science ®Google Scholar
• Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet356(9235), 1099–1104 (2000).
   PubMed Web of Science ®Google Scholar
• Brock I, Weldingh K, Leyten EM et al. Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J. Clin. Microbiol.42(6), 2379–2387 (2004).
   PubMed Web of Science ®Google Scholar
• Lalvani A, Millington KA. T cell-based diagnosis of childhood tuberculosis infection. Curr. Opin. Infect. Dis.20(3), 264–271 (2007).
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Chronic Conditions. Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control. Royal College of Physicians. Royal Imperial College, London, UK (2006).
   Google Scholar
• Ruiz-Manzano J, Blanquer R, Calpe JL et al. SEPAR Guidelines. Diagnostic and treatment of tuberculosis. Arch. Bronconeumol.44, 551–566 (2008).
   PubMed Web of Science ®Google Scholar
• Mazurek GH, Jereb J, Lobue P et al. Guidelines for using the QuantiFERON-TB Gold test for detectingMycobacterium tuberculosis infection, United States. MMWR Recomm. Rep.54(RR-15), 49–55 (2005).
   PubMedGoogle Scholar
• Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med.146(5), 340–354 (2007).
   PubMed Web of Science ®Google Scholar
• Ferrara G, Losi M, D’Amico R et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet367(9519), 1328–1334 (2006).
   PubMed Web of Science ®Google Scholar
• Kobashi Y, Mouri K, Obase Y et al. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. Eur. Respir. J.30(5), 945–950 (2007).
   PubMed Web of Science ®Google Scholar
• Richeldi L, Losi M, D’Amico R et al. Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest DOI:10.178/chest.08–2575 (2009) (Epub ahead of print).
   Google Scholar
• Duncan LE, Elliott AM, Hayes RJ et al. Tuberculin sensitivity and HIV-1 status of patients attending a sexually transmitted diseases clinic in Lusaka, Zambia: a cross-sectional study. Trans. R. Soc. Trop. Med. Hyg.89(1), 37–40 (1995).
   PubMedGoogle Scholar
• Markowitz N, Hansen NI, Wilcosky TC et al. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary complications of HIV Infection Study Group. Ann. Intern. Med.119(3), 185–193 (1993).
   PubMedGoogle Scholar
• Rangaka MX, Wilkinson KA, Seldon R et al. Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection. Am. J. Respir. Crit. Care Med.175(5), 514–520 (2007).
   PubMed Web of Science ®Google Scholar
• Mandalakas AM, Hesseling AC, Chegou NN et al. High level of discordant IGRA results in HIV-infected adults and children. Int. J. Tuberc. Lung Dis.12(4), 417–423 (2008).
   PubMed Web of Science ®Google Scholar
• Karam F, Mbow F, Fletcher H et al. Sensitivity of IFN-γ release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS ONE3(1), e1441 (2008).
   PubMedGoogle Scholar
• Luetkemeyer AF, Charlebois ED, Flores LL et al. Comparison of an interferon-γ release assay with tuberculin skin testing in HIV-infected individuals. Am. J. Respir. Crit. Care Med.175(7), 737–742 (2007).
   PubMed Web of Science ®Google Scholar
• Talati NJ, Seybold U, Humphrey B et al. Poor concordance between interferon-γ release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect. Dis.9, 15 (2009).
   PubMedGoogle Scholar
• Liebeschuetz S, Bamber S, Ewer K et al. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet364(9452), 2196–2203 (2004).
   PubMed Web of Science ®Google Scholar
• Vincenti D, Carrara S, Butera O et al. Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study. Clin. Exp. Immunol.150(1), 91–98 (2007).
   PubMedGoogle Scholar
• Brock I, Ruhwald M, Lundgren B et al. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-γ test. Respir. Res.7, 56 (2006).
   PubMed Web of Science ®Google Scholar
• Balcells ME, Perez CM, Chanqueo L et al. A comparative study of two different methods for the detection of latent tuberculosis in HIV-positive individuals in Chile. Int. J. Infect. Dis.12(6), 645–652 (2008).
   PubMed Web of Science ®Google Scholar
• Jones S, de Gijsel D, Wallach FR et al. Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals. Int. J. Tuberc. Lung Dis.11(11), 1190–1195 (2007).
   PubMed Web of Science ®Google Scholar
• Stephan C, Wolf T, Goetsch U et al. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS22(18), 2471–2479 (2008).
   PubMedGoogle Scholar
• Chapman AL, Munkanta M, Wilkinson KA et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS16(17), 2285–2293 (2002).
   PubMed Web of Science ®Google Scholar
• Dheda K, Lalvani A, Miller RF et al. Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS19(17), 2038–2041 (2005).
   PubMed Web of Science ®Google Scholar
• Clark SA, Martin SL, Pozniak A et al. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin. Exp. Immunol.150(2), 238–244 (2007).
   PubMed Web of Science ®Google Scholar
• Lawn SD, Bangani N, Vogt M et al. Utility of interferon-γ ELISPOT assay response in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. BMC Infect. Dis.7, 99 (2007).
   PubMedGoogle Scholar
• Hammond AS, McConkey SJ, Hill PC et al. Mycobacterial T cell responses in HIV-infected patients with advanced immunosuppression. J. Infect. Dis.197(2), 295–299 (2008).
   PubMedGoogle Scholar
• Rivas I, Latorre I, Sanvisens A et al. Prospective evaluation of latent tuberculosis with interferon-γ release assays in drug and alcohol abusers. Epidemiol. Infect.1–6 (2009).
   Google Scholar
• Raby E, Moyo M, Devendra A et al. The effects of HIV on the sensitivity of a whole blood IFN-γ release assay in Zambian adults with active tuberculosis. PLoS ONE3(6), e2489 (2008).
   PubMedGoogle Scholar
• Aabye MG, Ravn P, PrayGod G et al. The impact of HIV infection and CD4 cell count on the performance of an interferon γ release assay in patients with pulmonary tuberculosis. PLoS ONE4(1), e4220 (2009).
   Google Scholar
• Rangaka MX, Diwakar L, Seldon R et al. Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans. Clin. Infect. Dis.44(12), 1639–1646 (2007).
   PubMed Web of Science ®Google Scholar
• Aichelburg MC, Rieger A, Breitenecker F et al. Detection and prediction of active tuberculosis disease by a whole-blood interferon-γ release assay in HIV-1-infected individuals. Clin. Infect. Dis.48(7), 954–962 (2009).
   PubMed Web of Science ®Google Scholar
• Panes J, Gomollon F, Taxonera C et al. Crohn’s disease: a review of current treatment with a focus on biologics. Drugs67(17), 2511–2537 (2007).
   PubMed Web of Science ®Google Scholar
• Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum.48(8), 2122–2127 (2003).
   PubMed Web of Science ®Google Scholar
• Gardam MA, Keystone EC, Menzies R et al. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect. Dis.3(3), 148–155 (2003).
   PubMed Web of Science ®Google Scholar
• Keane J, Gershon S, Wise RP et al. Tuberculosis associated with infliximab, a tumor necrosis factor a-neutralizing agent. N. Engl. J. Med.345(15), 1098–1104 (2001).
   PubMed Web of Science ®Google Scholar
• Carmona L, Gomez-Reino JJ, Rodriguez-Valverde V et al. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum.52(6), 1766–1772 (2005).
   PubMed Web of Science ®Google Scholar
• Lalvani A, Millington KA. Screening for tuberculosis infection prior to initiation of anti-TNF therapy. Autoimmun. Rev.8(2), 147–152 (2008).
   PubMed Web of Science ®Google Scholar
• Domínguez J, Latorre I. Role of the T-cell interferon-γ release assays in preventing reactivation of latent tuberculosis infection in immunosuppressed patients in treatment with anti-TNF agents. J. Crohn’s & Colitis2, 250–254 (2008).
   PubMedGoogle Scholar
• Bocchino M, Matarese A, Bellofiore B et al. Performance of two commercial blood IFN-γ release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-α treatment. Eur. J. Clin. Microbiol. Infect. Dis.27(10), 907–913 (2008).
   PubMed Web of Science ®Google Scholar
• Cobanoglu N, Ozcelik U, Kalyoncu U et al. Interferon-γ assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-α blockers. Int. J. Tuberc. Lung Dis.11(11), 1177–1182 (2007).
   PubMedGoogle Scholar
• Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S et al. Comparison of an interferon-γ assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J. Rheumatol.35(5), 776–781 (2008).
   PubMedGoogle Scholar
• Vassilopoulos D, Stamoulis N, Hadziyannis E, Archimandritis AJ. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. J. Rheumatol.35(7), 1271–1276 (2008).
   PubMed Web of Science ®Google Scholar
• Matulis G, Juni P, Villiger PM, Gadola SD. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon γ assay. Ann. Rheum. Dis.67(1), 84–90 (2008).
   PubMed Web of Science ®Google Scholar
• Behar SM, Shin DS, Maier A et al. Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy. J. Rheumatol.36(3), 546–551. (2009).
   PubMed Web of Science ®Google Scholar
• Schoepfer AM, Flogerzi B, Fallegger S et al. Comparison of interferon-γ release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease. Am. J. Gastroenterol.103(11), 2799–2806 (2008).
   PubMed Web of Science ®Google Scholar
• Sellam J, Hamdi H, Roy C et al. Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy. Ann. Rheum. Dis.66(12), 1610–1615 (2007).
   PubMedGoogle Scholar
• Murakami S, Takeno M, Kirino Y et al. Screening of tuberculosis by interferon-γ assay before biologic therapy for rheumatoid arthritis. Tuberculosis (Edinb.)89(2), 136–141 (2009).
   PubMed Web of Science ®Google Scholar
• Martin J, Walsh C, Gibbs A et al. Comparison of interferon-γ-release assays and conventional screening tests before tumour necrosis factor-α blockade in patients with inflammatory arthritis. Ann. Rheum. Dis. DOI:10.1136/ard.2008. 101857 (2009) (Epub ahead of print).
   Google Scholar
• Takahashi H, Shigehara K, Yamamoto M et al. Interferon γ assay for detecting latent tuberculosis infection in rheumatoid arthritis patients during infliximab administration. Rheumatol. Int.27(12), 1143–1148 (2007).
   PubMed Web of Science ®Google Scholar
• Greenberg JD, Reddy SM, Schloss SG et al. Comparison of an in vitro tuberculosis interferon-γ assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis. J. Rheumatol.35(5), 770–775 (2008).
   PubMedGoogle Scholar
• Bartalesi F, Vicidomini S, Goletti D et al. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Eur. Respir. J.33(3), 586–593 (2009).
   PubMed Web of Science ®Google Scholar
• Hamdi H, Mariette X, Godot V et al. Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists. Arthritis Res. Ther.8(4), R114 (2006).
   PubMed Web of Science ®Google Scholar
• Chen DY, Shen GH, Hsieh TY, Hsieh CW, Lan JL. Effectiveness of the combination of a whole-blood interferon-γ assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy. Arthritis Rheum.59(6), 800–806 (2008).
   PubMedGoogle Scholar
• Pratt A, Nicholl K, Kay L. Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-α agents: the Newcastle (UK) experience. Rheumatology (Oxford)46(6), 1035–1036 (2007).
   PubMedGoogle Scholar
• Munoz P, Rodriguez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin. Infect. Dis.40(4), 581–587 (2005).
   PubMed Web of Science ®Google Scholar
• Manuel O, Humar A, Preiksaitis J et al. Comparison of Quantiferon-TB Gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am. J. Transplant.7(12), 2797–2801 (2007).
   PubMedGoogle Scholar
• Codeluppi M, Cocchi S, Guaraldi G et al. Posttransplant Mycobacterium tuberculosis disease following liver transplantation and the need for cautious evaluation of Quantiferon TB GOLD results in the transplant setting: a case report. Transplant. Proc.38(4), 1083–1085 (2006).
   PubMedGoogle Scholar
• Barsegian V, Mathias KD, Wrighton-Smith P, Grosse-Wilde H, Lindemann M. Prevalence of latent tuberculosis infection in German radiologists. J. Hosp. Infect.69, 60–76 (2008).
   Google Scholar
• Passalent L, Khan K, Richardson R et al. Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel. Clin. J. Am. Soc. Nephrol.2(1), 68–73 (2007).
   PubMed Web of Science ®Google Scholar
• Winthrop KL, Nyendak M, Calvet H et al. Interferon-γ release assays for diagnosing Mycobacterium tuberculosis infection in renal dialysis patients. Clin. J. Am. Soc. Nephrol.3(5), 1357–1363 (2008).
   PubMed Web of Science ®Google Scholar
• Triverio PA, Bridevaux PO, Roux-Lombard P et al. Interferon-γ release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol. Dial. Transplant. DOI:10.1093/ndt/gfn748 (2009) (Epub ahead of print).
   Google Scholar
• Lee SS, Chou KJ, Su IJ et al. High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection DOI:10.1007/s15010–008–8082–3 (2008) (Epub ahead of print).
   Google Scholar
• Hursitoglu M, Cikrikcioglu MA, Tukek T et al. Acute effect of low-flux hemodialysis process on the results of the interferon-γ-based QuantiFERON-TB Gold In-Tube test in end-stage renal disease patients. Transpl. Infect. Dis.11(1), 28–32 (2009).
   PubMedGoogle Scholar
• Piana F, Codecasa LR, Cavallerio P et al. Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients. Eur. Respir. J.28(1), 31–34 (2006).
   PubMed Web of Science ®Google Scholar
• Nicol MP, Pienaar D, Wood K et al. Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin. Infect. Dis.40(9), 1301–1308 (2005).
   PubMed Web of Science ®Google Scholar
• Connell TG, Curtis N, Ranganathan SC, Buttery JP. Performance of a whole blood interferon γ assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax61(7), 616–620 (2006).
   PubMed Web of Science ®Google Scholar
• Connell TG, Ritz N, Paxton GA et al. A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children. PLoS ONE3(7), e2624 (2008).
   Web of Science ®Google Scholar
• Richeldi L, Ewer K, Losi M et al. T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. Pediatrics119(1), e1–e5 (2007).
   Google Scholar
• Dogra S, Narang P, Mendiratta DK et al. Comparison of a whole blood interferon-γ assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J. Infect.54, 267–276 (2007).
   PubMed Web of Science ®Google Scholar
• Dominguez J, Ruiz-Manzano J, De Souza-Galvao M et al. Comparison of two commercially available γ interferon blood tests for immunodiagnosis of tuberculosis. Clin. Vaccine Immunol.15(1), 168–171 (2008).
   PubMedGoogle Scholar
• Kampmann B, Whittaker E, Williams A et al. Interferon-γ release assays do not identify more children with active TB than TST. Eur. Respir. J. DOI:10.1183/0903193600153408 (2009) (Epub ahead of print).
   Google Scholar
• Davies MA, Connell T, Johannisen C et al. Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay. AIDS23(8), 961–969 (2009).
   PubMed Web of Science ®Google Scholar
• Ewer K, Deeks J, Alvarez L et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet361(9364), 1168–1173 (2003).
   PubMed Web of Science ®Google Scholar
• Lalvani A, Pathan AA, Durkan H et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet357(9273), 2017–2021 (2001).
   PubMed Web of Science ®Google Scholar
• Richeldi L, Ewer K, Losi M et al. T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am. J. Respir. Crit. Care Med.170(3), 288–295 (2004).
   PubMed Web of Science ®Google Scholar
• Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am. J. Respir. Crit. Care Med.170(1), 65–69 (2004).
   PubMed Web of Science ®Google Scholar
• Hesseling AC, Mandalakas AM, Kirchner HL et al. Highly discordant T-cell responses in individuals with recent household tuberculosis exposure. Thorax DOI:10.1136/thx.2007.085340 (2008) (Epub ahead of print).
   Google Scholar
• Winje BA, Oftung F, Korsvold GE et al. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-γ release assay. BMC Infect. Dis.8, 140 (2008).
   PubMedGoogle Scholar
• Lewinsohn DA, Zalwango S, Stein CM et al. Whole blood interferon-γ responses to Mycobacterium tuberculosisantigens in young household contacts of persons with tuberculosis in Uganda. PLoS ONE3(10), e3407 (2008).
   Google Scholar
• Hill PC, Brookes RH, Adetifa MO et al. Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics117(5), 1542–1548 (2006).
   PubMed Web of Science ®Google Scholar
• Nakaoka H, Lawson L, Squire SB et al. Risk for tuberculosis among children. Emerg. Infect. Dis.12(9), 1383–1388 (2006).
   PubMed Web of Science ®Google Scholar
• Chun JK, Kim CK, Kim HS et al. The role of a whole blood interferon-γ assay for the detection of latent tuberculosis infection in Bacille Calmette–Guerin vaccinated children. Diagn. Microbiol. Infect. Dis.62(4), 389–394 (2008).
   PubMedGoogle Scholar
• de Jong BC, Hill PC, Brookes RH et al.Mycobacterium africanum elicits an attenuated T cell response to early secreted antigenic target, 6kDa, in patients with tuberculosis and their household contacts. J. Infect. Dis.193(9), 1279–1286 (2006).
   PubMed Web of Science ®Google Scholar
• Detjen AK, Keil T, Roll S et al. Interferon-γ release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin. Infect. Dis.45(3), 322–328 (2007).
   PubMed Web of Science ®Google Scholar
• Hill PC, Jeffries DJ, Brookes RH et al. Using ELISPOT to expose false positive skin test conversion in tuberculosis contacts. PLoS ONE2(1), e183 (2007).
   PubMedGoogle Scholar
• Lighter J, Rigaud M, Eduardo R, Peng CH, Pollack H. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test. Pediatrics123(1), 30–37 (2009).
   PubMed Web of Science ®Google Scholar
• Nicol MP, Davies MA, Wood K et al. Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics123(1), 38–43 (2009).
   PubMed Web of Science ®Google Scholar
• Bergamini BM, Losi M, Vaienti F et al. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics123(3), e419–e424 (2009).
   Web of Science ®Google Scholar
• Ewer K, Millington KA, Deeks JJ et al. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med.174(7), 831–839 (2006).
   PubMed Web of Science ®Google Scholar
• Hill PC, Brookes RH, Fox A et al. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PloS Med.4(6), e192 (2007).
   PubMed Web of Science ®Google Scholar
• Pai M, Dheda K, Cunningham J, Scano F, O’Brien R. T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect. Dis.7(6), 428–438 (2007).
   PubMed Web of Science ®Google Scholar
• Bakir M, Millington KA, Soysal A et al. Prognostic value of a T-cell-based, interferon-γ biomarker in children with tuberculosis contact. Ann. Intern. Med.149(11), 777–787 (2008).
   PubMed Web of Science ®Google Scholar
• Kim SH, Song KH, Choi SJ et al. Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis in immunocompromised patients. Am. J. Med.122(2), 189–195 (2009).
   PubMed Web of Science ®Google Scholar
• Richeldi L, Ewer K, Losi M et al. Early diagnosis of subclinical multidrug-resistant tuberculosis. Ann. Intern. Med.140(9), 709–713 (2004).
   PubMedGoogle Scholar
• Spyridis N, Chakraborty R, Sharland M, Heath PT. Early diagnosis of tuberculosis using an INF-γ assay in a child with HIV-1 infection and a very low CD4 count. Scand. J. Infect. Dis.39(10), 919–921 (2007).
   PubMed Web of Science ®Google Scholar
• Ravn P, Munk ME, Andersen AB et al. Reactivation of tuberculosis during immunosuppressive treatment in a patient with a positive QuantiFERON-RD1 test. Scand. J. Infect. Dis.36(6–7), 499–501 (2004).
   PubMed Web of Science ®Google Scholar
• Wilkinson KA, Wilkinson RJ, Pathan A et al.Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. Clin. Infect. Dis.40(1), 184–187 (2005).
   PubMed Web of Science ®Google Scholar
• Richeldi L, Luppi M, Losi M et al. Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. Leukemia20(2), 379–381 (2006).
   PubMedGoogle Scholar
• Lange C, Hellmich B, Ernst M, Ehlers S. Rapid immunodiagnosis of tuberculosis in a woman receiving anti-TNF therapy. N. Clin. Pract. Rheumatol.3(9), 528–534 (2007).
   PubMedGoogle Scholar
• Baba K, Sornes S, Hoosen AA et al. Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON TB-Gold interferon-γ assay. BMC Infect. Dis.8, 35 (2008).
   PubMed Web of Science ®Google Scholar
• Jafari C, Ernst M, Strassburg A et al. Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot. Eur. Respir. J.31(2), 261–265 (2008).
   PubMed Web of Science ®Google Scholar
• Strassburg A, Jafari C, Ernst M, Lotz W, Lange C. Rapid diagnosis of pulmonary TB by BAL enzyme-linked immunospot assay in an immunocompromised host. Eur. Respir. J.31(5), 1132–1135 (2008).
   PubMedGoogle Scholar
• Goletti D, Stefania C, Butera O et al. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study. PLoS ONE3(10), e3417 (2008).
   Web of Science ®Google Scholar
• Lalvani A, Nagvenkar P, Udwadia Z et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J. Infect. Dis.183(3), 469–477 (2001).
   PubMed Web of Science ®Google Scholar
• Richeldi L, Losi M, Cerri S et al. Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay. Expert Rev. Resp. Med.2(2), 253–260 (2007).
   Google Scholar
• Ravn P, Munk ME, Andersen AB et al. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin. Diagn. Lab. Immunol.12(4), 491–496 (2005).
   PubMedGoogle Scholar
• Domínguez J, De Souza-Galvao M, Ruiz-Manzano J et al. T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment. Diagn. Microbiol. Infect. Dis.63, 43–51 (2009).
   PubMed Web of Science ®Google Scholar
• Bothamley G. Interferon-γ-release assays in the managament of tuberculosis. Expert Rev. Resp. Med.1(3), 365–375 (2007).
   PubMedGoogle Scholar
• Soysal A, Millington KA, Bakir M et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet366(9495), 1443–1451 (2005).
   PubMed Web of Science ®Google Scholar
• Hill PC, Jackson-Sillah D, Fox A et al. Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS ONE3(1), e1379 (2008).
   PubMedGoogle Scholar
• Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole-blood IFN-γ assay for the development of active TB disease. Am. J. Respir. Crit. Care Med.177(10), 1164–1170 (2008).
   PubMed Web of Science ®Google Scholar
• Dominguez J, Ruiz-Manzano J. The tuberculin skin test: time for a change? Arch. Bronconeumol.42(2), 47–48 (2006).
   PubMedGoogle Scholar
• Mahomed H, Hughes EJ, Hawkridge T et al. Comparison of Mantoux skin test with three generations of a whole blood IFN-γ assay for tuberculosis infection. Int. J. Tuberc. Lung Dis.10(3), 310–316 (2006).
   PubMed Web of Science ®Google Scholar
• Richeldi L, Bergamini BM, Vaienti F. Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts. Eur. Respir. J.32(2), 524–525 (2008).
   PubMed Web of Science ®Google Scholar
• Choi JC, Shin JW, Kim JY et al. The effect of previous tuberculin skin test on the follow-up examination on whole-blood interferon-γ assay in the screening for latent tuberculosis infection. Chest133(6), 1415–1420 (2008).
   PubMed Web of Science ®Google Scholar
• Naseer A, Naqvi S, Kampmann B. Evidence for boosting Mycobacterium tuberculosis-specific IFN-γ responses at 6 weeks following tuberculin skin testing. Eur. Respir. J.29(6), 1282–1283 (2007).
   PubMed Web of Science ®Google Scholar
• Richeldi L, Ewer K, Losi M et al. Repeated tuberculin testing does not induce false positive ELISPOT results. Thorax61(2), 180 (2006).
   PubMed Web of Science ®Google Scholar
• Leyten EM, Prins C, Bossink AW et al. Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-γ assay. Eur. Respir. J.29(6), 1212–1216 (2007).
   PubMed Web of Science ®Google Scholar
• Lalvani A, Millington KA. T-cell interferon-γ release assays: can we do better? Eur. Respir. J.32(6), 1428–1430 (2008).
   PubMedGoogle Scholar
• Liu XQ, Dosanjh DP, Varia H et al. Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection. Infect. Immun.72(5), 2574–2581 (2004).
   PubMedGoogle Scholar
• Ruhwald M, Bodmer T, Maier C et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur. Respir. J.32(6), 1607–1615 (2008).
   PubMed Web of Science ®Google Scholar
• Millington KA, Innes JA, Hackforth S et al. Dynamic relationship between IFN-γ and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J. Immunol.178(8), 5217–5226 (2007).
   PubMed Web of Science ®Google Scholar